# Utilizing loop-mediated isothermal amplification (LAMP) for detecting hemoglobin Constant Spring and hemoglobin Pakse mutations amidst the high prevalence and genetic heterogeneity of thalassemia in Thailand

**Authors:** Kasama Wongprachum, Nichakan Thitipoomdecha, Phakkamon Ananratanakit, Wattanakit Prakobkul, Unchasa Angkuranak, Nitchagan Sawangkul, Prapaporn Panichchob, Rossarin Karnpean, Wittaya Jomoui

PMC · DOI: 10.7717/peerj.19687 · PeerJ · 2025-07-07

## TL;DR

A new LAMP assay is developed for detecting Hb Constant Spring and Hb Pakse mutations in Thailand, offering a fast, accurate, and affordable diagnostic tool for thalassemia.

## Contribution

A novel colorimetric LAMP assay with high sensitivity and specificity for detecting two specific α-globin gene mutations in thalassemia.

## Key findings

- The LAMP assay achieved 100% sensitivity and specificity in detecting Hb CS and Hb PS mutations across 282 DNA samples.
- The assay has a detection limit of 0.625 ng/reaction and provides results within 35 minutes at 65°C using a phenol red pH indicator.
- The method is cost-effective and suitable for use in community hospitals and large-scale screenings in resource-limited settings.

## Abstract

Thalassemia is a genetic disorder with significant prevalence in Southeast Asia, particularly in Thailand, where hemoglobin (Hb) Constant Spring (Hb CS) and hemoglobin Pakse (Hb PS) mutations are common. These mutations, resulting from stop codon alterations in the α2-globin gene, can lead to severe phenotypes such as non-deletional Hb H disease. This study aimed to develop and evaluate a novel colorimetric loop-mediated isothermal amplification (LAMP) assay for detecting Hb CS and Hb PS mutations. A total of 282 samples with several genotypes were recruited in the study. We developed LAMP assay, using a phenol red pH indicator, which provided visual detection of DNA amplification within 35 minutes at 65 °C. Both assays demonstrated a lower limit of detection of 0.625 ng/reaction and achieved 100% sensitivity and specificity across 282 DNA samples, validated against standard allele-specific polymerase chain reaction (PCR). Additionally, the assay’s minimal equipment requirements and cost-effectiveness make it suitable for use in community hospitals and large-scale screenings. The LAMP assay offers a rapid, accurate, and affordable alternative for Hb CS and Hb PS detection, addressing the challenges of managing thalassemia in genetically diverse and resource-limited regions like Thailand.

## Linked entities

- **Diseases:** thalassemia (MONDO:0000984)

## Full-text entities

- **Genes:** BCS1L (BCS1 ubiquinol-cytochrome c reductase complex chaperone) [NCBI Gene 617] {aka BCS, BCS1, BJS, FLNMS, GRACILE, Hs.6719}, HBA2 (hemoglobin subunit alpha 2) [NCBI Gene 3040] {aka ECYT7, HBA-T2, HBH}
- **Diseases:** Hb H disease (MESH:D017085), genetic disorder (MESH:D030342), Thalassemia (MESH:D013789)
- **Chemicals:** phenol red (MESH:D010637)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12244126/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12244126/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12244126/full.md

---
Source: https://tomesphere.com/paper/PMC12244126